<html><head><meta content="text/html; charset=UTF-8" http-equiv="content-type"><style type="text/css">ul.lst-kix_k304g9ngkpfw-2{list-style-type:none}ul.lst-kix_k304g9ngkpfw-3{list-style-type:none}.lst-kix_m3dcm8svcykw-4>li:before{content:"\0025cb   "}.lst-kix_m3dcm8svcykw-5>li:before{content:"\0025a0   "}ul.lst-kix_k304g9ngkpfw-0{list-style-type:none}ul.lst-kix_k304g9ngkpfw-1{list-style-type:none}.lst-kix_m3dcm8svcykw-2>li:before{content:"\0025a0   "}.lst-kix_m3dcm8svcykw-6>li:before{content:"\0025cf   "}.lst-kix_m3dcm8svcykw-3>li:before{content:"\0025cf   "}.lst-kix_8cc8347bx6bu-5>li:before{content:"\0025a0   "}.lst-kix_8cc8347bx6bu-6>li:before{content:"\0025cf   "}.lst-kix_m3dcm8svcykw-8>li:before{content:"\0025a0   "}ul.lst-kix_k304g9ngkpfw-8{list-style-type:none}ul.lst-kix_k304g9ngkpfw-6{list-style-type:none}.lst-kix_8cc8347bx6bu-7>li:before{content:"\0025cb   "}ul.lst-kix_k304g9ngkpfw-7{list-style-type:none}.lst-kix_m3dcm8svcykw-7>li:before{content:"\0025cb   "}ul.lst-kix_k304g9ngkpfw-4{list-style-type:none}.lst-kix_8cc8347bx6bu-8>li:before{content:"\0025a0   "}ul.lst-kix_k304g9ngkpfw-5{list-style-type:none}.lst-kix_tmrd84xyi4w-5>li:before{content:"\0025a0   "}.lst-kix_tmrd84xyi4w-4>li:before{content:"\0025cb   "}.lst-kix_tmrd84xyi4w-6>li:before{content:"\0025cf   "}.lst-kix_hjdu446h2v72-8>li:before{content:"\0025a0   "}ul.lst-kix_x9nzonfxlat7-0{list-style-type:none}ul.lst-kix_x9nzonfxlat7-1{list-style-type:none}ul.lst-kix_x9nzonfxlat7-2{list-style-type:none}ul.lst-kix_x9nzonfxlat7-3{list-style-type:none}.lst-kix_tmrd84xyi4w-1>li:before{content:"\0025cb   "}.lst-kix_hjdu446h2v72-6>li:before{content:"\0025cf   "}ul.lst-kix_x9nzonfxlat7-4{list-style-type:none}ul.lst-kix_x9nzonfxlat7-5{list-style-type:none}.lst-kix_tmrd84xyi4w-0>li:before{content:"\0025cf   "}.lst-kix_tmrd84xyi4w-8>li:before{content:"\0025a0   "}ul.lst-kix_x9nzonfxlat7-6{list-style-type:none}ul.lst-kix_x9nzonfxlat7-7{list-style-type:none}.lst-kix_tmrd84xyi4w-7>li:before{content:"\0025cb   "}ul.lst-kix_x9nzonfxlat7-8{list-style-type:none}.lst-kix_hjdu446h2v72-7>li:before{content:"\0025cb   "}.lst-kix_hjdu446h2v72-2>li:before{content:"\0025a0   "}.lst-kix_g9z23921qfnf-3>li:before{content:"\0025cf   "}.lst-kix_hjdu446h2v72-0>li:before{content:"\0025cf   "}.lst-kix_hjdu446h2v72-4>li:before{content:"\0025cb   "}.lst-kix_g9z23921qfnf-1>li:before{content:"\0025cb   "}.lst-kix_g9z23921qfnf-2>li:before{content:"\0025a0   "}.lst-kix_k304g9ngkpfw-3>li:before{content:"\0025cf   "}.lst-kix_hjdu446h2v72-1>li:before{content:"\0025cb   "}.lst-kix_hjdu446h2v72-5>li:before{content:"\0025a0   "}.lst-kix_g9z23921qfnf-0>li:before{content:"\0025cf   "}.lst-kix_k304g9ngkpfw-4>li:before{content:"\0025cb   "}.lst-kix_k304g9ngkpfw-5>li:before{content:"\0025a0   "}.lst-kix_tmrd84xyi4w-2>li:before{content:"\0025a0   "}.lst-kix_tmrd84xyi4w-3>li:before{content:"\0025cf   "}.lst-kix_k304g9ngkpfw-6>li:before{content:"\0025cf   "}.lst-kix_hjdu446h2v72-3>li:before{content:"\0025cf   "}ul.lst-kix_hjdu446h2v72-6{list-style-type:none}.lst-kix_x9nzonfxlat7-3>li:before{content:"\0025cf   "}.lst-kix_x9nzonfxlat7-4>li:before{content:"\0025cb   "}ul.lst-kix_hjdu446h2v72-5{list-style-type:none}ul.lst-kix_hjdu446h2v72-8{list-style-type:none}ul.lst-kix_hjdu446h2v72-7{list-style-type:none}.lst-kix_x9nzonfxlat7-1>li:before{content:"\0025cb   "}.lst-kix_x9nzonfxlat7-5>li:before{content:"\0025a0   "}ul.lst-kix_hjdu446h2v72-0{list-style-type:none}ul.lst-kix_hjdu446h2v72-2{list-style-type:none}.lst-kix_k304g9ngkpfw-2>li:before{content:"\0025a0   "}.lst-kix_x9nzonfxlat7-2>li:before{content:"\0025a0   "}ul.lst-kix_hjdu446h2v72-1{list-style-type:none}ul.lst-kix_hjdu446h2v72-4{list-style-type:none}ul.lst-kix_hjdu446h2v72-3{list-style-type:none}.lst-kix_k304g9ngkpfw-0>li:before{content:"\0025cf   "}.lst-kix_k304g9ngkpfw-1>li:before{content:"\0025cb   "}ul.lst-kix_m3dcm8svcykw-8{list-style-type:none}ul.lst-kix_m3dcm8svcykw-6{list-style-type:none}ul.lst-kix_m3dcm8svcykw-7{list-style-type:none}ul.lst-kix_m3dcm8svcykw-4{list-style-type:none}ul.lst-kix_m3dcm8svcykw-5{list-style-type:none}ul.lst-kix_m3dcm8svcykw-2{list-style-type:none}.lst-kix_x9nzonfxlat7-7>li:before{content:"\0025cb   "}.lst-kix_x9nzonfxlat7-8>li:before{content:"\0025a0   "}ul.lst-kix_m3dcm8svcykw-3{list-style-type:none}ul.lst-kix_m3dcm8svcykw-0{list-style-type:none}ul.lst-kix_m3dcm8svcykw-1{list-style-type:none}.lst-kix_x9nzonfxlat7-6>li:before{content:"\0025cf   "}ul.lst-kix_8cc8347bx6bu-6{list-style-type:none}ul.lst-kix_8cc8347bx6bu-7{list-style-type:none}ul.lst-kix_8cc8347bx6bu-4{list-style-type:none}ul.lst-kix_8cc8347bx6bu-5{list-style-type:none}ul.lst-kix_8cc8347bx6bu-8{list-style-type:none}.lst-kix_x9nzonfxlat7-0>li:before{content:"\0025cf   "}.lst-kix_ow4qxko5tuv1-0>li:before{content:"\0025cf   "}.lst-kix_ow4qxko5tuv1-1>li:before{content:"\0025cb   "}ul.lst-kix_g9z23921qfnf-8{list-style-type:none}ul.lst-kix_g9z23921qfnf-7{list-style-type:none}ul.lst-kix_g9z23921qfnf-6{list-style-type:none}ul.lst-kix_g9z23921qfnf-5{list-style-type:none}.lst-kix_ow4qxko5tuv1-6>li:before{content:"\0025cf   "}ul.lst-kix_ow4qxko5tuv1-0{list-style-type:none}ul.lst-kix_ow4qxko5tuv1-1{list-style-type:none}ul.lst-kix_ow4qxko5tuv1-2{list-style-type:none}ul.lst-kix_ow4qxko5tuv1-3{list-style-type:none}ul.lst-kix_ow4qxko5tuv1-4{list-style-type:none}.lst-kix_ow4qxko5tuv1-5>li:before{content:"\0025a0   "}ul.lst-kix_ow4qxko5tuv1-5{list-style-type:none}ul.lst-kix_ow4qxko5tuv1-6{list-style-type:none}.lst-kix_ow4qxko5tuv1-4>li:before{content:"\0025cb   "}ul.lst-kix_8cc8347bx6bu-2{list-style-type:none}.lst-kix_ow4qxko5tuv1-2>li:before{content:"\0025a0   "}ul.lst-kix_8cc8347bx6bu-3{list-style-type:none}ul.lst-kix_8cc8347bx6bu-0{list-style-type:none}.lst-kix_ow4qxko5tuv1-3>li:before{content:"\0025cf   "}ul.lst-kix_8cc8347bx6bu-1{list-style-type:none}ul.lst-kix_ow4qxko5tuv1-7{list-style-type:none}ul.lst-kix_ow4qxko5tuv1-8{list-style-type:none}ul.lst-kix_tmrd84xyi4w-0{list-style-type:none}ul.lst-kix_tmrd84xyi4w-1{list-style-type:none}ul.lst-kix_tmrd84xyi4w-2{list-style-type:none}ul.lst-kix_tmrd84xyi4w-3{list-style-type:none}ul.lst-kix_tmrd84xyi4w-4{list-style-type:none}ul.lst-kix_tmrd84xyi4w-5{list-style-type:none}ul.lst-kix_tmrd84xyi4w-6{list-style-type:none}ul.lst-kix_tmrd84xyi4w-7{list-style-type:none}ul.lst-kix_tmrd84xyi4w-8{list-style-type:none}.lst-kix_k304g9ngkpfw-8>li:before{content:"\0025a0   "}.lst-kix_k304g9ngkpfw-7>li:before{content:"\0025cb   "}.lst-kix_g9z23921qfnf-4>li:before{content:"\0025cb   "}.lst-kix_g9z23921qfnf-5>li:before{content:"\0025a0   "}.lst-kix_g9z23921qfnf-6>li:before{content:"\0025cf   "}.lst-kix_g9z23921qfnf-7>li:before{content:"\0025cb   "}.lst-kix_g9z23921qfnf-8>li:before{content:"\0025a0   "}.lst-kix_8cc8347bx6bu-3>li:before{content:"\0025cf   "}li.li-bullet-0:before{margin-left:-18pt;white-space:nowrap;display:inline-block;min-width:18pt}.lst-kix_8cc8347bx6bu-4>li:before{content:"\0025cb   "}ul.lst-kix_g9z23921qfnf-0{list-style-type:none}.lst-kix_ow4qxko5tuv1-7>li:before{content:"\0025cb   "}.lst-kix_ow4qxko5tuv1-8>li:before{content:"\0025a0   "}ul.lst-kix_g9z23921qfnf-4{list-style-type:none}ul.lst-kix_g9z23921qfnf-3{list-style-type:none}ul.lst-kix_g9z23921qfnf-2{list-style-type:none}.lst-kix_8cc8347bx6bu-2>li:before{content:"\0025a0   "}ul.lst-kix_g9z23921qfnf-1{list-style-type:none}.lst-kix_8cc8347bx6bu-1>li:before{content:"\0025cb   "}.lst-kix_m3dcm8svcykw-0>li:before{content:"\0025cf   "}.lst-kix_m3dcm8svcykw-1>li:before{content:"\0025cb   "}.lst-kix_8cc8347bx6bu-0>li:before{content:"\0025cf   "}ol{margin:0;padding:0}table td,table th{padding:0}.c8{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:204pt;border-top-color:#000000;border-bottom-style:solid}.c27{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:174.8pt;border-top-color:#000000;border-bottom-style:solid}.c9{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:118.5pt;border-top-color:#000000;border-bottom-style:solid}.c44{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left;height:11pt}.c26{background-color:#ffffff;padding-top:12pt;padding-bottom:12pt;line-height:1.5;orphans:2;widows:2;text-align:left}.c47{background-color:#ffffff;padding-top:0pt;padding-bottom:11pt;line-height:1.9615384615384615;orphans:2;widows:2;text-align:left}.c7{color:#000000;text-decoration:none;vertical-align:baseline;font-size:10pt;font-family:"Arial";font-style:normal}.c20{padding-top:14pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c5{padding-top:18pt;padding-bottom:4pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c31{padding-top:14pt;padding-bottom:4pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c17{padding-top:24pt;padding-bottom:6pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c11{padding-top:12pt;padding-bottom:12pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c34{padding-top:12pt;padding-bottom:12pt;line-height:1.15;orphans:2;widows:2;text-align:center}.c22{color:#000000;text-decoration:none;vertical-align:baseline;font-size:23pt;font-family:"Arial"}.c21{color:#000000;text-decoration:none;vertical-align:baseline;font-size:13pt;font-family:"Arial"}.c28{color:#000000;text-decoration:none;vertical-align:baseline;font-size:20pt;font-family:"Arial"}.c2{color:#000000;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial"}.c18{color:#000000;text-decoration:none;vertical-align:baseline;font-size:17pt;font-family:"Arial"}.c30{color:#000000;text-decoration:none;vertical-align:baseline;font-size:8pt;font-family:"Arial"}.c45{padding-top:0pt;padding-bottom:12pt;line-height:1.15;text-align:left}.c41{margin-left:auto;border-spacing:0;border-collapse:collapse;margin-right:auto}.c10{padding-top:0pt;padding-bottom:0pt;line-height:1.0;text-align:left}.c6{text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;text-decoration:underline}.c14{vertical-align:baseline;font-size:11pt;font-family:"Arial"}.c33{background-color:#fff2cc;color:#980000;text-decoration:none}.c43{background-color:#ffffff;max-width:468pt;padding:72pt 72pt 72pt 72pt}.c35{text-decoration:none;vertical-align:baseline;font-family:"Arial"}.c40{color:#000000;font-size:16pt}.c19{padding:0;margin:0}.c15{color:inherit;text-decoration:inherit}.c12{margin-left:36pt;padding-left:0pt}.c16{margin-left:72pt;padding-left:0pt}.c24{border:1px solid black;margin:5px}.c3{color:#1a1a1a;font-size:16pt}.c38{color:#000000;font-size:13pt}.c0{font-style:italic}.c39{color:#1155cc}.c32{font-size:12pt}.c42{font-size:13pt}.c13{font-style:normal}.c1{font-weight:700}.c23{color:#595959}.c25{font-size:11pt}.c4{font-weight:400}.c29{height:0pt}.c37{font-size:17pt}.c46{height:11pt}.c36{font-size:23pt}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}h1{padding-top:20pt;color:#000000;font-size:20pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:18pt;color:#000000;font-size:16pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:16pt;color:#434343;font-size:14pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style></head><body class="c43 doc-content"><p class="c34"><span class="c2 c13 c1">Donated Drug Reporting Templates to Support Neglected Tropical Disease (NTD) Program Implementation WHO SMART Guidelines approach</span></p><h1 class="c17" id="h.l0oqhcgdhhyi"><span class="c22 c13 c1">Program Overview</span></h1><h2 class="c5" id="h.p71edloitjy6"><span class="c18 c13 c1">1. Program Name</span></h2><p class="c11"><span class="c0">Donated Drug Reporting Templates to Support Neglected Tropical Disease (NTD) Program</span></p><h2 class="c5" id="h.phybjjyfg5gy"><span class="c18 c13 c1">2. Sponsoring Organization(s)</span></h2><p class="c45"><span class="c0 c23">John</span><span class="c0 c23">&nbsp;Snow, Inc.[</span><span class="c6 c0"><a class="c15" href="https://www.google.com/url?q=https://www.jsi.com/&amp;sa=D&amp;source=editors&amp;ust=1739205885874954&amp;usg=AOvVaw2HbeuOtXKjcWNLPaszfseO">link</a></span><span class="c0 c23">]</span><span class="c0 c23">&nbsp;and Standard Co [</span><span class="c6 c0"><a class="c15" href="https://www.google.com/url?q=https://www.standardco.de/&amp;sa=D&amp;source=editors&amp;ust=1739205885875147&amp;usg=AOvVaw2dvXbRCCeMZfEw0q_mDhB3">link</a></span><span class="c0 c23">], with financial support from the Bill &amp; Melinda Gates Foundation [</span><span class="c6 c0"><a class="c15" href="https://www.google.com/url?q=https://www.gatesfoundation.org/&amp;sa=D&amp;source=editors&amp;ust=1739205885875307&amp;usg=AOvVaw2eR6pjiPlD3PsdAz-QAOcx">link</a></span><span class="c0 c23">], conducted an assessment of the tools and processes used to manage, direct, use, report, and store last mile tools and processes used to manage donated medicines used for Neglected Tropical Disease (NTD) control and elimination programmes for the five PC-NTDs.</span></p><h2 class="c5" id="h.jy49ste2m4io"><span class="c18 c13 c1">3. Geographic Coverage</span></h2><p class="c11"><span class="c0">While this project focused on evaluating the people, systems, and processes used to track last mile supply chain for Mass Drug Administration (MDA) donated medicines in eight priority countries (DRC, Ethiopia, Kenya, Madagascar, Mozambique, Nigeria, Tanzania, and Uganda), the recommendation templates are applicable for reporting inventory of MDA donated medicines in any country with considerations for unique country context.</span></p><h2 class="c5" id="h.srh2t44xw539"><span class="c13 c1 c18">4. Target Population</span></h2><p class="c11"><span class="c0">The target population for this tool is national NTD Program Managers, implementing NGO partners, and project sponsors. The timely reporting of data on donated medicines received, used, wasted, expired, and remaining, helps to ensure that the production and distribution of new medicines are delivered to sites around the world for distribution to endemic communities in the appropriate quantities.</span></p><h1 class="c17" id="h.meqzv4fu5ry6"><span class="c22 c13 c1">Alignment with WHO Smart Guidelines</span></h1><h2 class="c5" id="h.npmhpg1mx6zj"><span class="c18 c13 c1">5. WHO Recommendations for NTDs</span></h2><p class="c11"><span class="c0">In 2022, the World Health Organization (WHO) published the &ldquo;Standard Operating Procedures for Supply Chain Management of Health Products for Neglected Tropical Diseases Amenable to Preventive Chemotherapy.&rdquo; [</span><span class="c6 c0"><a class="c15" href="https://www.google.com/url?q=https://www.who.int/publications/i/item/9789240049581?utm_source%3Dchatgpt.com&amp;sa=D&amp;source=editors&amp;ust=1739205885876108&amp;usg=AOvVaw0j4W1Nh__X-ePUok7UGl2D">link</a></span><span class="c2 c0 c4">] &nbsp;This document provides detailed procedures covering various aspects of supply chain management, including:</span></p><ul class="c19 lst-kix_x9nzonfxlat7-0 start"><li class="c11 c12 li-bullet-0"><span class="c0 c1">Forecasting and Quantification:</span><span class="c2 c0 c4">&nbsp;Accurate estimation of medicine requirements to prevent shortages or overstocking.</span></li><li class="c11 c12 li-bullet-0"><span class="c0 c1">Inventory Management:</span><span class="c2 c0 c4">&nbsp;Systematic tracking of stock levels to maintain optimal inventory.</span></li><li class="c11 c12 li-bullet-0"><span class="c0 c1">Storage and Distribution:</span><span class="c2 c0 c4">&nbsp;Proper storage conditions and timely distribution to ensure medicine efficacy.</span></li><li class="c11 c12 li-bullet-0"><span class="c0 c1">Reverse Logistics:</span><span class="c2 c0 c4">&nbsp;Processes for handling and reporting unused or expired medicines.</span></li></ul><p class="c11"><span class="c0">The mechanism for reporting medicines is through the Joint Application Package (JAP) [</span><span class="c6 c0"><a class="c15" href="https://www.google.com/url?q=https://www.who.int/teams/control-of-neglected-tropical-diseases/interventions/strategies/preventive-chemotherapy/joint-application-package&amp;sa=D&amp;source=editors&amp;ust=1739205885876643&amp;usg=AOvVaw3kdgXlQDCKcIa6cxdRWQpn">link</a></span><span class="c0">]. This package is a collection of forms and includes forms for reporting on medicines delivered through the Joint Reporting Form (JRF), and medicines needed for future treatments through the Joint Request for Select Medicines (JRSM). These forms are submitted to WHO by national NTD Program Managers annually. Forms are reviewed and submitted to pharmaceutical partners who produce the medicines and ship the medicines to countries for distribution to endemic communities.</span></p><h2 class="c5" id="h.ko9nxlf7k14v"><span class="c18 c13 c1">6. Digital Adaptation Kit (DAK) Components</span></h2><h3 class="c31" id="h.sizosd87zgr5"><span class="c1 c38">Functional &amp; Non-functional Requirement</span><sup><a href="#cmnt1" id="cmnt_ref1">[a]</a></sup></h3><p class="c11"><span class="c2 c13 c1">Functional requirements</span></p><p class="c11"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 2048.00px; height: 371.00px;"><img alt="" src="images/image3.png" style="width: 2048.00px; height: 371.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span class="c1"><br></span><span class="c6"><a class="c15" href="https://www.google.com/url?q=https://docs.google.com/spreadsheets/d/1yPYo4qOwWxHHD6ckmXrLE4VMVU0kWGPy/edit?usp%3Ddrive_link%26ouid%3D104620825587987098442%26rtpof%3Dtrue%26sd%3Dtrue&amp;sa=D&amp;source=editors&amp;ust=1739205885877256&amp;usg=AOvVaw3yj2LFwiWT4GjXLhPf1zHE">Web annex B</a></span></p><p class="c11"><span class="c2 c13 c1">Non-functional requirements </span></p><p class="c11"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 2048.00px; height: 445.00px;"><img alt="" src="images/image1.png" style="width: 2048.00px; height: 445.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><span class="c1"><br></span><span class="c6"><a class="c15" href="https://www.google.com/url?q=https://docs.google.com/spreadsheets/d/1yPYo4qOwWxHHD6ckmXrLE4VMVU0kWGPy/edit?usp%3Ddrive_link%26ouid%3D104620825587987098442%26rtpof%3Dtrue%26sd%3Dtrue&amp;sa=D&amp;source=editors&amp;ust=1739205885877534&amp;usg=AOvVaw2uawryWlUAoSNTmNJ1Yb03">Web annex B</a></span></p><h3 class="c31" id="h.hews4sso2cwl"><span class="c21 c13 c1">Data Models and Exchange</span></h3><p class="c11"><span class="c1">Actors - </span><span class="c2 c13 c1">entities that interact with the system, derived from business requirements</span></p><table class="c41"><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c2 c13 c1">Name</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c2 c13 c1">Administrative level</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c2 c13 c1">Description</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Community member</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Community</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Target for MDA treatment</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Community Health Worker (CHW)</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Community</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Distribute MDA and report data associated with treatments delivered. The system could be implemented at this level.</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">District Health Worker</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">District</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">District is the level of reporting treatments on annual reporting forms. This is the most likely level of implementing this system given the resources available at this level.</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">NTD Program Manager</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">National</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Collect data from all districts and report these data on annual reporting forms. National level could produce reports from data reported by either community or district level.</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">WHO Country Office</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c4 c7">National</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Support national programs to complete annual reporting forms. Would have limited impact on this system.</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">WHO Regional Office</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Regional</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">First review of annual reporting forms. If this level was given access to data collected by this system, annual reporting forms could be pre populated through integration.</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">WHO Central Office</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Global</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Final review of drug donation request. Would have limited use for this system.</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Pharmaceutical company </span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Global</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Integration with this system would allow for early reporting of drugs used, wasted, and remaining. These data would improve forecasting for manufacturing.</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">International shipment company</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Global</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Would have limited impact on this system. However, the shipping information is available for integration with national systems and that data combined with reporting medicine stock would provide a comprehensive review of received, used, requested medicines.</span></p></td></tr><tr class="c29"><td class="c8" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Implementing partner</span></p></td><td class="c9" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Global</span></p></td><td class="c27" colspan="1" rowspan="1"><p class="c10"><span class="c7 c4">Implementing partners would have no role in using this system. However, if they were given access to these data they too would have improved visibility on inventory and expiration.</span></p></td></tr></table><p class="c11 c46"><span class="c2 c13 c1"></span></p><p class="c11"><span class="c1">List of indicators across multiple tools</span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 742.99px; height: 347.19px;"><img alt="" src="images/image2.png" style="width: 742.99px; height: 347.19px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c20"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 1184.00px; height: 998.00px;"><img alt="" src="images/image4.png" style="width: 1184.00px; height: 998.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span><sup><a href="#cmnt2" id="cmnt_ref2">[b]</a></sup><span class="c1 c42"><br></span><span class="c6 c25"><a class="c15" href="https://www.google.com/url?q=https://docs.google.com/spreadsheets/d/1_NCdu7_UhALA5o2GEe1pdlWO8TMZLDX8/edit?usp%3Ddrive_link%26ouid%3D104620825587987098442%26rtpof%3Dtrue%26sd%3Dtrue&amp;sa=D&amp;source=editors&amp;ust=1739205885882464&amp;usg=AOvVaw1RxdV6VAfurBpnXL--kRS9">Web annex A</a></span></p><h3 class="c31" id="h.cg5p8cbxroo"><span class="c21 c13 c1">Workflows &amp; Business Processes</span></h3><p class="c11"><span class="c0">The </span><span class="c0 c1">first mile</span><span class="c0">&nbsp;refers to the initial stages of the supply chain, from the pharmaceutical manufacturers or donors to the national or regional distribution centers. For NTD programs, first mile supply chain processes can be tracked through NTDeliver [</span><span class="c0 c6"><a class="c15" href="https://www.google.com/url?q=https://www.ntdeliver.com/about&amp;sa=D&amp;source=editors&amp;ust=1739205885882754&amp;usg=AOvVaw1avP6Pyd_TSqXnY06Ise1F">link</a></span><span class="c2 c0 c4">].</span></p><p class="c11"><span class="c0">The </span><span class="c0 c1">last mile</span><span class="c2 c0 c4">&nbsp;refers to the final stages of distribution, from national storage facilities to the community-level health workers or end-users. The activities and challenges associated with the last mile are the focus of this project and associated tools.</span></p><p class="c11"><span class="c2 c0 c1">Key Activities:</span></p><ul class="c19 lst-kix_k304g9ngkpfw-0 start"><li class="c11 c12 li-bullet-0"><span class="c2 c0 c1">Transport to Regional &amp; Local Distribution Points:</span></li></ul><ul class="c19 lst-kix_k304g9ngkpfw-1 start"><li class="c11 c16 li-bullet-0"><span class="c0">National storage centers distribute medicines to </span><span class="c0 c1">regional or district health offices</span><span class="c2 c0 c4">.</span></li></ul><ul class="c19 lst-kix_k304g9ngkpfw-0"><li class="c11 c12 li-bullet-0"><span class="c2 c0 c1">Community-Level Distribution (MDA Campaigns):</span></li></ul><ul class="c19 lst-kix_k304g9ngkpfw-1 start"><li class="c11 c16 li-bullet-0"><span class="c0">Community drug distributors (CDDs), often volunteers, administer medicines directly to at-risk populations through </span><span class="c0 c1">door-to-door</span><span class="c2 c0 c4">, school-based, or health center campaigns.</span></li><li class="c11 c16 li-bullet-0"><span class="c0">Real-time tracking and </span><span class="c0 c1">paper-based or digital recording</span><span class="c0">&nbsp;ensure </span><span class="c0 c1">dosage compliance</span><span class="c2 c0 c4">.</span></li></ul><ul class="c19 lst-kix_k304g9ngkpfw-0"><li class="c11 c12 li-bullet-0"><span class="c0 c1 c2">Reverse Logistics &amp; Waste Management:</span></li></ul><ul class="c19 lst-kix_k304g9ngkpfw-1 start"><li class="c11 c16 li-bullet-0"><span class="c2 c0 c4">Expired or unused drugs are collected, stored, and expired medicines are safely disposed of.</span></li></ul><p class="c11"><span class="c0">Weak monitoring and reporting systems can lead to </span><span class="c0 c1">stockouts or over-distribution</span><span class="c2 c0 c4">&nbsp;of medicines. Most often, the medicines used for MDA campaigns are not tracked using national logistics management information systems as they move from ports of entry, to central storage, and, ultimately, out to endemic communities. Similarly, reporting of the use of these medicines is a component of paper-based community registers and treatment summary forms. Limiting the access to these data until weeks after the MDA has concluded.</span></p><p class="c11"><span style="overflow: hidden; display: inline-block; margin: 0.00px -0.00px; border: 1.33px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 539.48px; height: 404.28px;"><img alt="" src="images/image5.png" style="width: 539.48px; height: 404.28px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c11"><span class="c0">The tools provided here support the electronic submission of drug distribution during, or immediately following the MDA to a central database where these data can be accessed by all key actors and used for program management, reporting, and planning.</span></p><h3 class="c31" id="h.pfqg4gckja90"><span class="c38 c1">Reporting Specifications</span></h3><p class="c11"><span class="c0 c1">XLSForm</span><span class="c0">&nbsp;[</span><span class="c6 c0"><a class="c15" href="https://www.google.com/url?q=https://xlsform.org/en/%23what-is-an-xlsform?&amp;sa=D&amp;source=editors&amp;ust=1739205885884116&amp;usg=AOvVaw3clNHCi1sIC2DMaSdlHoIh">link</a></span><span class="c0">] is a widely used open standard that ensures consistent implementation of advanced features like skip logic across various web and mobile data collection platforms. It enables users to author forms in a human-readable format with a familiar tool, Microsoft Excel, making collaboration and sharing more accessible. Tools that support XLSForms are commonly used in </span><span class="c0 c1">humanitarian aid, public health, and development projects</span><span class="c2 c0 c4">&nbsp;due to their flexibility and interoperability.</span></p><p class="c11"><span class="c2 c0 c4">Compatible web and mobile data collection platforms supporting XLSForm includes:</span></p><ul class="c19 lst-kix_8cc8347bx6bu-0 start"><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Open Data Kit (ODK)</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">KoboToolbox</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Enketo Web Forms</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Ona</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">SurveyCTO</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">CommCare</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">EpiCollect5</span></li><li class="c11 c12 li-bullet-0"><span class="c0">Standard Data</span></li></ul><h1 class="c17" id="h.5s1m6x8ma876"><span class="c13 c1 c22">Data Management &amp; Decision Support</span></h1><h2 class="c5" id="h.om3ny3yoaa7v"><span class="c18 c13 c1">7. Data Collection &amp; Reporting</span></h2><p class="c11"><span class="c2 c0 c4">It is recommended that data are reported from whatever level is feasible given literacy, human resource constraints, and infrastructure constraints. </span></p><p class="c11"><span class="c2 c0 c1">Community level</span></p><p class="c11"><span class="c2 c0 c4">Ideally, data on MDA medicines distribution would be submitted from endemic communities on a daily basis. This would allow program managers and supervisors to monitor the progress of MDA and to make critical decisions when inventory deficits and surpluses need to be moved around. </span></p><p class="c11"><span class="c2 c0 c1">Sub-district or district level</span></p><p class="c11"><span class="c0">When community level reporting is not feasible, reporting would move to a higher administrative level, which would reduce the number of reporters, but also limit what actions could be taken with these data. Data submitted above the community level would primarily support the reporting of treatments delivered and remaining stock on annual reporting forms. These data could be made available to WHO and pharmaceutical partners, improving their ability to manufacture and ship medicines on time.</span></p><h2 class="c5" id="h.am6921ch0tk1"><span class="c18 c13 c1">8. Decision Support Artifacts</span></h2><p class="c11"><span class="c2 c0 c4">Decisions from these data include:</span></p><ul class="c19 lst-kix_x9nzonfxlat7-0"><li class="c11 c12 li-bullet-0"><span class="c0 c1">Forecasting and Quantification:</span><span class="c2 c0 c4">&nbsp;Accurate estimation of medicine requirements to prevent shortages or overstocking.</span></li></ul><ul class="c19 lst-kix_x9nzonfxlat7-1 start"><li class="c11 c16 li-bullet-0"><span class="c2 c0 c4">Are the quantities of drugs in a community sufficient to treat the target population?</span></li></ul><ul class="c19 lst-kix_x9nzonfxlat7-0"><li class="c11 c12 li-bullet-0"><span class="c0 c1">Inventory Management:</span><span class="c2 c0 c4">&nbsp;Systematic tracking of stock levels to maintain optimal inventory.</span></li></ul><ul class="c19 lst-kix_x9nzonfxlat7-1 start"><li class="c11 c16 li-bullet-0"><span class="c2 c0 c4">If a community has a surplus or deficit, can these drugs be moved to or from adjoining communities?</span></li></ul><ul class="c19 lst-kix_x9nzonfxlat7-0"><li class="c11 c12 li-bullet-0"><span class="c0 c1">Storage and Distribution:</span><span class="c0">&nbsp;Proper storage conditions and timely distribution to ensure medicine efficacy &amp; </span><span class="c0 c1">Reverse Logistics:</span><span class="c2 c0 c4">&nbsp;Processes for handling and reporting unused or expired medicines.</span></li></ul><ul class="c19 lst-kix_x9nzonfxlat7-1 start"><li class="c11 c16 li-bullet-0"><span class="c2 c0 c4">What quantity of medicines will remain on hand after the MDA, where will they be stored, and will their expiration date allow them to be used in future MDA?</span></li><li class="c11 c16 li-bullet-0"><span class="c0">Review of the quantities of drugs expiring to improve future distribution forecast</span></li></ul><h1 class="c17" id="h.rq4n7zl6mpu3"><span class="c22 c13 c1">Implementation &amp; Integration</span></h1><h2 class="c5" id="h.eyiull71q7bf"><span class="c18 c13 c1">9. Digital Health Systems Integration</span></h2><p class="c11"><span class="c0">There are multiple opportunities for system integration between the tools presented here and national Health Information Management Systems (HMIS), Logistic Information Management Systems (LMIS), NTD databases or data repositories, and, at the global level, WHO and NTDeliver.</span></p><h2 class="c5" id="h.3z9frs13p4df"><span class="c1 c37">10. Monitoring &amp; Evaluation Metrics</span></h2><p class="c11"><span class="c2 c0 c4">Data are likely reported by district or reported by sub-district and aggregated to district for WHO annual reporting forms.<br><br> The key performance indicators (KPIs) for this tool are the following:</span></p><ul class="c19 lst-kix_ow4qxko5tuv1-0 start"><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Quantity of medical product(s) received</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Quantity of medical product(s) use</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Quantity of medical product(s) wasted</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Quantity of medical product(s) expired</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Quantity of medical product(s) remaining (calculated: received - (used+wasted+expired))</span></li><li class="c11 c12 li-bullet-0"><span class="c2 c0 c4">Quantity of medical product(s) required for future treatments (calculated: needed - remaining)</span></li></ul><p class="c11"><span class="c2 c0 c4">Reporting timelines:</span></p><p class="c11"><span class="c0">Currently, inventory is reported once annually on the JAP annual reporting forms from countries to WHO. However, this cadence of reporting lacks interim visibility. Receiving all national drug requests at the same time places a burden on the manufacturing and shipment of donated medicines to endemic countries. The tools presented here provide an </span><span class="c0 c1">opportunity to report quantities of medical products at the time of distribution</span><span class="c2 c0 c4">, providing greater visibility and the opportunity to integrate these data into manufacturing forecast models.</span></p><h1 class="c17" id="h.yydhodze5w09"><span class="c22 c13 c1">References &amp; Dependencies</span></h1><h2 class="c5" id="h.uir4hu4ghff4"><span class="c18 c13 c1">11. WHO Guidelines &amp; Resources</span></h2><ul class="c19 lst-kix_tmrd84xyi4w-0 start"><li class="c11 c12 li-bullet-0"><span>WHO Smart Guidelines: </span><span class="c6"><a class="c15" href="https://www.google.com/url?q=https://www.who.int/teams/digital-health-and-innovation/smart-guidelines&amp;sa=D&amp;source=editors&amp;ust=1739205885886464&amp;usg=AOvVaw3uAkjVDQi9xlZxLNs9-hDV">Link</a></span></li><li class="c11 c12 li-bullet-0"><span>WHO NTD Recommendations: </span><span class="c6"><a class="c15" href="https://www.google.com/url?q=https://www.who.int/teams/immunization-vaccines-and-biologicals&amp;sa=D&amp;source=editors&amp;ust=1739205885886636&amp;usg=AOvVaw2VrCUb1bTwuQhsJON5fYbT">Link</a></span></li><li class="c11 c12 li-bullet-0"><span>Smart Guidelines References: </span><span class="c6"><a class="c15" href="https://www.google.com/url?q=https://worldhealthorganization.github.io/smart-example-immz/references.html&amp;sa=D&amp;source=editors&amp;ust=1739205885886801&amp;usg=AOvVaw054t54b4sRHH4goJyPjAbz">Link</a></span></li><li class="c11 c12 li-bullet-0"><span>Dependencies: </span><span class="c6"><a class="c15" href="https://www.google.com/url?q=https://worldhealthorganization.github.io/smart-example-immz/dependencies.html&amp;sa=D&amp;source=editors&amp;ust=1739205885886965&amp;usg=AOvVaw0RThN2c-JwPex6CfpO78Wb">Link</a></span><span class="c1 c3"><br></span></li></ul><h1 class="c47" id="h.o9tg4b82vdp7"><span class="c1 c36">Web annexes</span></h1><ul class="c19 lst-kix_m3dcm8svcykw-0 start"><li class="c26 c12 li-bullet-0"><span class="c6 c32"><a class="c15" href="https://www.google.com/url?q=https://docs.google.com/spreadsheets/d/1_NCdu7_UhALA5o2GEe1pdlWO8TMZLDX8/edit?usp%3Ddrive_link%26ouid%3D104620825587987098442%26rtpof%3Dtrue%26sd%3Dtrue&amp;sa=D&amp;source=editors&amp;ust=1739205885887244&amp;usg=AOvVaw2uwppD0SDqz008_EPZMp6W">Web annex A: Indicator table</a></span></li><li class="c26 c12 li-bullet-0"><span class="c6 c32"><a class="c15" href="https://www.google.com/url?q=https://docs.google.com/spreadsheets/d/1yPYo4qOwWxHHD6ckmXrLE4VMVU0kWGPy/edit?usp%3Ddrive_link%26ouid%3D104620825587987098442%26rtpof%3Dtrue%26sd%3Dtrue&amp;sa=D&amp;source=editors&amp;ust=1739205885887434&amp;usg=AOvVaw1ToesMkV6K7QT9nXD2E0Mk">Web annex B: Functional and non-functional requirements</a></span></li><li class="c12 c26 li-bullet-0"><span class="c39 c32">LINK TO XLSFORMS!!</span><sup><a href="#cmnt3" id="cmnt_ref3">[c]</a></sup></li></ul><p class="c44"><span class="c2 c13 c4"></span></p><div class="c24"><p class="c10"><a href="#cmnt_ref1" id="cmnt1">[a]</a><span class="c2 c4 c13">I am not happy with these tables.&nbsp;TO DO STILL</span></p></div><div class="c24"><p class="c10"><a href="#cmnt_ref2" id="cmnt2">[b]</a><span class="c2 c13 c4">This is not good.&nbsp;TO DO STILL</span></p></div><div class="c24"><p class="c10"><a href="#cmnt_ref3" id="cmnt3">[c]</a><span class="c2 c13 c4">TO DO STILL</span></p></div></body></html>
